Antimicrobial Resistance Surveillance Market is predicted to reach USD 10.2 billion at a CAGR of 5.90% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Antimicrobial Resistance Surveillance Market”.

The Antimicrobial Resistance Surveillance market is estimated to register a CAGR of 5.90% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Antimicrobial Resistance Surveillance market— Thermo Fisher Scientific Inc., BioMérieux SA, Becton, Dickinson and Company, Danaher Corporation, Roche Diagnostics International Ltd., Siemens Healthineers, Bruker Corporation, Agilent Technologies, Inc., Abbott Laboratories, Cepheid Inc. and Others.

Market Highlights

The global Antimicrobial Resistance Surveillance market is accounted to register a CAGR of 5.90% during the forecast period and is estimated to reach USD 10.2 billion by 2032.

The antimicrobial resistance surveillance market is experiencing growth due to several factors. Increased awareness about the threat of antimicrobial resistance, coupled with rising incidences of resistant infections, drives the demand for surveillance solutions. Government initiatives promoting antimicrobial stewardship programs further fuel market expansion. Additionally, advancements in technology, such as genomics and molecular diagnostics, enhance surveillance capabilities, leading to early detection and management of resistant pathogens. This growing market addresses the critical need for effective strategies in combating antimicrobial resistance.

Access Full Report @ https://www.marketresearchfuture.com/reports/antimicrobial-resistance-surveillance-market-21967

Segment Analysis

The global Antimicrobial Resistance Surveillance market has been segmented into Solution, Application and End User.

On the basis of Solution, the market is segmented into Kits, System, Surveillance Software and Service. The kits segment dominated the Antimicrobial Resistance Surveillance market primarily due to its comprehensive offerings, including easy-to-use diagnostic kits for rapid detection of resistant pathogens. These kits provide accurate results with minimal turnaround time, facilitating timely interventions. Moreover, Kits Solution's strong distribution network and strategic partnerships enabled widespread adoption of its products, consolidating its position as the market leader in antimicrobial resistance surveillance in 2023.

Based on Application, the global Antimicrobial Resistance Surveillance market has been segmented into Clinical Diagnostics and Public Health Surveillance. The clinical diagnostics segment secured the largest market share in 2023 within the Antimicrobial Resistance Surveillance Market due to its critical role in identifying and managing resistant infections in healthcare settings. Its emphasis on early detection and accurate diagnosis of antimicrobial-resistant pathogens enhances patient care outcomes. Additionally, the integration of clinical diagnostics into routine healthcare practices and the growing demand for point-of-care testing further propelled its market dominance.

Based on End User, the global Antimicrobial Resistance Surveillance market has been segmented into Hospitals, Clinics, Academic and Research Institutes. The hospitals segment in the Antimicrobial Resistance Surveillance Market in 2023 due to their central role in managing infectious diseases and patient care. With a high patient volume and susceptibility to healthcare-associated infections, hospitals prioritize antimicrobial resistance surveillance to ensure effective treatment protocols and infection control measures. Moreover, the implementation of antimicrobial stewardship programs in hospitals drives the demand for surveillance solutions.

Regional Analysis

The global Antimicrobial Resistance Surveillance market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Antimicrobial Resistance Surveillance market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Antimicrobial Resistance Surveillance market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Antimicrobial Resistance Surveillance market comprises of Middle East, Africa, and Latin America.

North America led the Antimicrobial Resistance Surveillance Market, due to its advanced healthcare infrastructure, rigorous regulatory standards, and heightened awareness about antimicrobial resistance. The region's proactive approach to addressing infectious diseases, coupled with robust investments in surveillance technologies and antimicrobial stewardship programs, contributed to its dominant market position by facilitating early detection and management of resistant pathogens.

Europe secured the second-largest market share in the Antimicrobial Resistance Surveillance Market due to its robust healthcare infrastructure, proactive government initiatives, and strong focus on infection prevention and control. The region's stringent regulatory environment, coupled with increasing awareness about antimicrobial resistance, drove the adoption of surveillance solutions. Additionally, the presence of key market players and ongoing research activities further supported Europe's position in the market.

Asia Pacific is experiencing the highest compound annual growth rate (CAGR) in the Antimicrobial Resistance Surveillance Market due to several factors. These include rising incidences of antimicrobial resistance, increasing healthcare expenditure, expanding awareness about infectious diseases, and growing investments in healthcare infrastructure and research. Moreover, the region's large population and improving healthcare systems contribute to the significant growth potential of antimicrobial resistance surveillance solutions in Asia Pacific.

Furthermore, the rest of the world's Antimicrobial Resistance Surveillance market is divided into the Middle East, Africa, and Latin America. The rest of the world is witnessing growth in the Antimicrobial Resistance Surveillance market due to escalating incidences of antimicrobial resistance, expanding healthcare infrastructure, and rising awareness about infectious diseases. Additionally, increasing investments in healthcare technologies and initiatives to combat antimicrobial resistance drive market expansion in these regions.

Key Findings of the Study

• The global Antimicrobial Resistance Surveillance market is expected to reach USD 10.2 billion by 2032, at a CAGR of 5.90% during the forecast period.


• The Asia Pacific region is experiencing rapid growth in the Antimicrobial Resistance Surveillance market due to rising incidences of antimicrobial resistance, expanding healthcare infrastructure, increasing awareness, and substantial investments in healthcare technologies.


• Based on application, the Clinical Diagnostics segment was attributed to holding the largest market in 2023.


• Thermo Fisher Scientific Inc., BioMérieux SA, Becton, Dickinson and Company, Danaher Corporation, Roche Diagnostics International Ltd., Siemens Healthineers, Bruker Corporation, Agilent Technologies, Inc., Abbott Laboratories, Cepheid Inc. and Others.